PEOPLE - ResMed makes appointment:
This article was originally published in Clinica
Executive Summary
Kieran Gallahue is being promoted to CEO of ResMed, a Poway, California-based specialist in devices for sleep apnoea and other respiratory conditions, effective January 1 2008. Mr Gallahue, currently president and COO of the ResMed Global division, will replace company founder Dr Peter Farrell, who will remain as executive chairman of the board until June 30, becoming non-executive chairman thereafter. Mr Gallahue joined as president and COO of the Americas division in January 2003.
You may also be interested in...
EU’s SCCS Finds Endocrine-Disrupting Evidence Inconclusive In UV Filter Reassessments
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: